| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Sands Earl is a Chief Medical Officer at Cartesian Therapeutics, Inc.. Recent SEC Form 4 filings include 1 buy and 0 sells.
Estimated insider holdings value: $63K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 17, 2017 | RNAC Cartesian Therapeutics, Inc. | Chief Medical Officer | Buy | 7,500 | $10.26 | $76,966.50 | New |